Skip to main content

Global Minimally Invasive Neurosurgical Systems Market Is Anticipated to Reach $1,237.6 Million by The End of 2030

 According to a new market intelligence report by BIS Research titled ‘Global Minimally Invasive Neurosurgical Systems Market − Analysis and Forecast, 2020-2030’, the global minimally invasive neurosurgical systems market, which was valued at $417.7 million in 2019 and is anticipated to reach $1,237.6 million by the end of 2030, growing at a CAGR of 11.8% during the forecast period 2020-2030.

BIS Research Report: https://bisresearch.com/industry-report/minimally-invasive-neurosurgical-systems-market.html

The introduction of new technologies, practices, and methodologies has a significant impact on the global minimally invasive neurosurgical systems market. Constant competition among market players ensures that leading players in the market are innovative in terms of usability of the systems as well as their features. Several factors, such as the shift in preference for safer options than open cranial surgeries, increasing preference for instruments with more dexterity, increasing affordability, and technological advances in the field of artificial intelligence (AI), haptics, and telesurgery are expected to play a key role in the growth of the market during the forecast period 2020-2030.

Request for Sample Report:  https://bisresearch.com/requestsample?id=1009&type=download

The preference for minimally invasive neurosurgical procedures is expected to increase during the period 2020-2030, with robotic-assisted surgeries quickly gaining the market share. Furthermore, the growing demand for minimally invasive neurosurgical procedures is likely to be propelled through offering a more connected interface, motion scaling, and tremor filtration.

The high cost of neurosurgical robotic systems is one of the key factors restraining the growth in the adoption of surgical robotics technology. The adoption of robotic surgery systems incurs high installation and maintenance costs. Additionally, lack of skilled professionals is a challenge to the growth of this market. Among the factors contributing to adverse events during robotic-assisted surgeries, user errors and inadequately trained surgeons cumulatively account for nearly one-third of the total factors.

The following are the key questions for which this study provides holistic analysis:

§  What is the current market size and future potential of these products? 

§  What is the current market share and growth share of the different products in the market?

§  What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive neurosurgical systems?

§  What are the major market drivers, restraints, and opportunities in the global minimally invasive neurosurgical systems market?

§  What is the impact of the COVID-19 pandemic on the market?

§  Which technology is being researched and worked upon to improve the neurosurgical systems?


About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.


 












Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...